Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03781492

Stable Angina Management and Treatment

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is an observational study on an all-comer stable angina population hospitalised in a highly specialized cardiovascular centre with cardiac surgery facilities. The aim of the study is to assess the clinical characteristics, treatment modalities, early and long-term outcomes in this population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

3rd Chair and Department of Cardiology of Silesian Centre for Heart Diseases

Zabrze, Silesian Voivodeship, 41-800, Poland

Location status: Recruiting

Location contact

Mariusz Gąsior, Prof, MD, PhD

CONTACT

About this study

The Prospective REgistry of Stable Angina manaGEment and Treatment (PRESAGE) is a single-center, observational study recruiting consecutive patients with stable angina, who were diagnosed and treated in the 3rd Chair and Department of Cardiology in the Silesian Centre for Heart Diseases in Zabrze, Poland. The Silesian Centre for Heart Diseases is a highly specialised cardiology centre with cardiac surgery facilities

The main objective of the PRESAGE Registry is to clarify the overall clinical characteristics of patients with stable angina, their demographics and clinical profile, current management, early and long-term outcomes, with regard to the administered treatment.

The diagnosis of stable angina was based on clinical characterization, coronary angiography, and the current guidelines of the European Society of Cardiology. Patients with vasospastic and/or microvascular angina were also included to the registry. Performance of coronary angiography is the criterion of the enrolment in the registry.

Patients with acute coronary syndromes are excluded from the analysis.

Data collection is patient-based (not event-based).

Complete patient demographics: medical history, complete hospitalization data (diagnostic and therapeutic) and in-hospital results are collected in an electronic form by the attending physician. The patients are under constant follow-up for all-cause mortality and major cardiac adverse events.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • symptom based diagnosis of stable angina

Exclusion criteria

  • acute coronary syndrome on admission
  • ≤ 18 years old

Treatment and study plan

Primary outcomes

  1. Number of participants with reported deaths from any cause

    Time frame: From date of inclusion until the date of death from any cause, assessed up to 5 year

Secondary outcomes

  1. Number of participants with reported myocardial infarction

    Time frame: From date of inclusion until the date of first event, assessed up to 5 year

  2. Number of participants with reported cerebrovascular insult

    Time frame: From date of inclusion until the date of first event, assessed up to 5 year

  3. Number of participants with reported acute coronary syndrome driven revascularisation

    Time frame: From date of inclusion until the date of first event, assessed up to 5 year

Study contacts

Contact information is provided by the study sponsor or research team.

Piotr Desperak, MD

CONTACT

[email protected]

+48514374167

Sponsors and collaborators

Lead sponsor

Silesian Centre for Heart Diseases

Other

Registry information

Official study title

Prospective REgistry of Stable Angina manaGEment and Treatment

Acronym: PRESAGE

Important dates

Study start
2006
Primary completion
2026
Study completion
2026
First posted
Dec 20, 2018
Registry last updated
May 26, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.